The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Modified intention to treat reporting in randomised controlled trials: systematic review
Open accessAbstract
OBJECTIVES: To determine the incidence and characteristics of randomised controlled trials that report using the modified intention to treat approach, and how the approach is described. DESIGN: Systematic review. DATA SOURCES: PubMed, Embase, Cochrane central register of controlled trials, ISI Web of Knowledge, Ovid, HighWire Press, Science-Direct, Ingenta, Medscape, BioMed Central, Springer, and Wiley, from inception to December 2006. MAIN OUTCOME MEASURES: Incidence of trials in which use of modified intention to treat was reported, and how the approach was described (classified according to the type and number of deviations from the intention to treat approach). RESULTS: 475 randomised controlled trials reported use of a modified intention to treat analysis. Of these, 76 (16%) were published in five highly cited general medical journals. The incidence of all trials that reported use of modified intention to treat published in journals indexed in Medline increased from 0.006% in 1982-6 to 0.5% in 2002-6 (P<0.001 for linear trend). When the description of the modified intention to treat was examined in each trial, 192 (40%) reported one type of deviation from the intention to treat approach, 261 (55%) reported two or more types, and 22 (5%) did not describe any type. In 266 (56%) of the trials the deviation was related to the treatment received, in 196 (41%) to a post baseline assessment, in 118 (25%) to a baseline assessment, in 108 (23%) to a target condition, and in 23 (5%) to follow-up. Post-randomisation exclusions occurred in 380 (80%) trials. The results reported by 270 of the 352 (77%) superiority trials favoured the drug under investigation. All of the 123 trials using equivalence or non-inferiority methods to investigate interventions reported results that favoured their assumptions. CONCLUSIONS: Randomised controlled trials that report using a modified intention to treat are increasingly being published in the medical literature. The descriptions of such an approach were ambiguous, and may cover any type of descriptions for exclusion, such as missing data and deviation from protocol. Explicit statements about post-randomisation exclusions should replace the ambiguous terminology of modified intention to treat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
Schwartz, G. G. (2001) · JAMA · doi:10.1001/jama.285.13.1711 · Cited by 2,499
What is meant by intention to treat analysis? Survey of published randomised controlled trials
Hollis, S., & Campbell, F. (1999) · BMJ · doi:10.1136/bmj.319.7211.670 · Cited by 2,160
Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Moher, D., Jones, A., Lepage, L., & for the CONSORT Group (2001) · JAMA · doi:10.1001/jama.285.15.1992 · Cited by 1,027
Saiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell III, P. W., et al. (2003) · JAMA · doi:10.1001/jama.290.13.1749 · Cited by 958
Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszynska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 919
Plint, A. C., Moher, D., Morrison, A., Schulz, K., Altman, D. G., Hill, C., & Gaboury, I. (2006) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00557.x · Cited by 872
Intention-to-Treat Analysis: Implications for Quantitative and Qualitative Research
NEWELL, D. J. (1992) · International Journal of Epidemiology · doi:10.1093/ije/21.5.837 · Cited by 715
D'Agostino, R. B., Massaro, J. M., & Sullivan, L. M. (2003) · Statistics in Medicine · doi:10.1002/sim.1425 · Cited by 715
Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis
Fergusson, D., Aaron, S. D., Guyatt, G., & Hébert, P. (2002) · BMJ · doi:10.1136/bmj.325.7365.652 · Cited by 708 · cited 1×
“The literature reports different types of missing data and different reasons for data being missed.”
BackgroundMelander, H., Ahlqvist-Rastad, J., Meijer, G., & Beermann, B. (2003) · BMJ · doi:10.1136/bmj.326.7400.1171 · Cited by 635
Chan, A.-W., & Altman, D. G. (2005) · BMJ · doi:10.1136/bmj.38356.424606.8f · Cited by 613 · cited 1×
“This preponderance can be a consequence of many outcomes, and authors may selectively report secondary analysis depending on the P value.”
BackgroundWood, A. M., White, I. R., & Thompson, S. G. (2004) · Clinical Trials · doi:10.1191/1740774504cn032oa · Cited by 543
Epidemiology and reporting of randomised trials published in PubMed journals
Chan, A.-W., & Altman, D. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71879-1 · Cited by 474
Analyzing incomplete longitudinal clinical trial data
Molenberghs, G. (2004) · Biostatistics · doi:10.1093/biostatistics/5.3.445 · Cited by 463
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research
Chan, A.-W. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041086 · Cited by 444
Raine, T. R., Harper, C. C., Rocca, C. H., Fischer, R., Padian, N., Klausner, J. D., & Darney, P. D. (2005) · JAMA · doi:10.1001/jama.293.1.54 · Cited by 312
Nuesch, E., Trelle, S., Reichenbach, S., Rutjes, A. W. S., Burgi, E., Scherer, M., Altman, D. G., & Juni, P. (2009) · BMJ · doi:10.1136/bmj.b3244 · Cited by 248
Intention to treat – who should use ITT?
Lewis, J., & Machin, D. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.402 · Cited by 235
Investigating patient exclusion bias in meta-analysis
Tierney, J. F. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh300 · Cited by 221
Chan, A.-W., Hrobjartsson, A., Jorgensen, K. J., Gotzsche, P. C., & Altman, D. G. (2008) · BMJ · doi:10.1136/bmj.a2299 · Cited by 202
Altman, D. G., & Bland, J. M. (2007) · BMJ · doi:10.1136/bmj.38977.682025.2c · Cited by 196
Missing outcomes in randomized trials: addressing the dilemma.
Altman, D. G. (2009) · PubMed Central · Cited by 192
Berek, J. S., Taylor, P. T., Gordon, A., Cunningham, M. J., Finkler, N., Orr, J., Rivkin, S., Schultes, B. C., Whiteside, T. L., & Nicodemus, C. F. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.016 · Cited by 191
Discordance between reported intention-to-treat and per protocol analyses
Porta, N., Bonet, C., & Cobo, E. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.09.013 · Cited by 189
Farnier, M., Freeman, M. W., Macdonell, G., Perevozskaya, I., Davies, M. J., Mitchel, Y. B., & Gumbiner, B. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi231 · Cited by 161
Schwartz, G. G., OLSSON, A. G., & al, M. D. E. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00368-3 · Cited by 151
Gravel, J., Opatrny, L., & Shapiro, S. (2007) · Clinical Trials · doi:10.1177/1740774507081223 · Cited by 138
Lessons From and Cautions About Noninferiority and Equivalence Randomized Trials
Gøtzsche, P. C. (2006) · JAMA · doi:10.1001/jama.295.10.1172 · Cited by 106
CORONARY-ARTERY BYPASS SURGERY IN STABLE ANGINA PECTORIS: SURVIVAL AT TWO YEARS
(1979) · The Lancet · doi:10.1016/s0140-6736(79)91372-2 · Cited by 103
Greenspan, S. L., Field-Munves, E., Tonino, R. P., Smith, M. E., Petruschke, R. A., Wang, L., Yates, J., de Papp, A. E., & Palmisano, J. J. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.10.1044 · Cited by 93
Believability of relative risks and odds ratios in abstracts: Cross sectional study.
Gøtzsche, P. C. (2006) · BMJ · doi:10.1136/bmj.38895.410451.79 · Cited by 85
Intention to treat analysis is related to methodological quality
Ruiz‐Canela, M. (2000) · BMJ · doi:10.1136/bmj.320.7240.1007 · Cited by 76
(2002) · PubMed · Cited by 74
Solomkin, J. S., Wilson, S. E., Christou, N. V., Rotstein, O. D., Dellinger, E. P., Bennion, R. S., Pak, R. C. K., & Tack, K. J. (2001) · Annals of Surgery · doi:10.1097/00000658-200101000-00013 · Cited by 59
Young, J. M., Feldman, R., Auerbach, S. M., Kaufman, J. M., Garcia, C. S., Shen, W., Murphy, A. M., Beasley, C. M., Hague, J. A., & Ahuja, S. (2005) · Journal of Andrology · doi:10.2164/jandrol.04126 · Cited by 58
Intention-to-Treat vs. On-Treatment Analyses of Clinical Trial Data
Chêne, G., Morlat, P., Leport, C., Hafner, R., Dequae, L., Charreau, I., Aboulker, J.-P., Luft, B. J., Aubertin, J., Vildé, J., et al. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00145-1 · Cited by 56
The effects of non-compliance on intent-to-treat analysis of equivalence trials
Sheng, D., & Kim, M. (2005) · Statistics in Medicine · doi:10.1002/sim.2230 · Cited by 41
[Better reporting of harms in randomized trials: an extension of the CONSORT statement].
Gøtzsche, P. C. (2005) · PubMed · Cited by 36
Farnier, M., Freeman, M. W., & Macdonell, G. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.08.205 · Cited by 8
Cited by
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ · doi:10.1136/bmj.e7586 · Cited by 6,251
Intention-to-treat concept: A review
Gupta, S. (2011) · Perspectives in Clinical Research · doi:10.4103/2229-3485.83221 · Cited by 1,921
Assessing risk of bias in a randomized trial
Higgins, J. P., Savović, J., Page, M. J., Elbers, R. G., & Sterne, J. A. (2019) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9781119536604.ch8 · Cited by 1,765
Fretland, Å. A., Dagenborg, V. J., Bjørnelv, G. M. W., Kazaryan, A. M., Kristiansen, R., Fagerland, M. W., Hausken, J., Tønnessen, T. I., Abildgaard, A., Barkhatov, L., et al. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002353 · Cited by 703
Metadata
- Authors
- Abraha, I., & Montedori, A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2010-06-14
- Volume
- 340
- Issue
- jun14 1
- Pages
- c2697-c2697
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2048142893
- Cited by
- 255
- References
- 44
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.